Polycystic Kidney Disease: The Research Behind the First Treatment, and Augusta's Part in It
ADPKD affects 1 in 400 to 1,000 people. The trial behind its first approved treatment ran partly in Augusta. What the disease is, what tolvaptan does, what comes next, and what families can do now.
